Tevosol, Inc., a medical device company, appoints transplant industry veteran Ron Mills as its Chief Executive Officer (CEO).Ron possesses more than 30 years of rich experience in healthcare communications, brand strategy, and venture creation, along with 20 years in organ transplantation and regenerative medicine. He has led the global market development and commercialization for LifePort Kidney Transporter for Organ Recovery Systems, the market leader in organ preservation, from 2000- 2007.

Hailing from Detroit, Ron holds degrees in Literature from the University of Michigan. Prior to joining Organ Recovery Systems, he served as the Director of Communications for the Chicago and Great Lakes Consulting practice of Ernst & Young, an independent writer and editor, and a biopharma advertising executive.Ron set up Maelstream Startups in 2007, an independent consultancy based in Evanston, Illinois, where he served as launch strategist for drugs, devices, and dotcoms; as interim executives at Publicis, Syneos (InVentiv), and McCann; and as an advisor to the transplantation community.

In 2018 Ron joined Tevosol in Edmonton, Alberta, Canada.

Commenting on the appointment, Dr.Darren Freed, Tevosol Co-founder and Chief Scientist Officer says, “Ron knows our technology and our market, he brings a wealth of relevant experience to our team and adds a spark of creativity to drive the next exciting stage of our enterprise. Tevosol is fortunate to have Ron Mills at the helm.” He also appreciated Ron for his success in cultivating strong relationships with transplant surgeons, organ preservation coordinators & techs, and organizations across the transplantation community.

Ron knows our technology and our market, he brings a wealth of relevant experience to our team and adds a spark of creativity to drive the next exciting stage of our enterprise. Tevosol is fortunate to have Ron Mills at the helm.

Tevosol, Inc. is an early stage medical device company focused on developing EVOSS™ (Ex-Vivo Organ Support System). A portable perfusion machine built around the living, working organ at normal body temperature, EVOSS™ will help surgeons recover, resuscitate, transport, evaluate, and transplant more donor organs and help scientists unlock new sources that will solve the organ shortage.